MMR Vaccination Might Be The Reason Younger People Are At Less Risk For COVID-19
A study from the University of Cambridge suggests those who received the MMR vaccine (Measles, Mumps and Rubella) may have some protection against SARS-CoV-2.
They found a 29% similarity between the Rubella virus and SARS-CoV-2.
Lead authors state the structure of Rubella may be similar enough to that of the novel coronavirus that the immunity induced from the MMR vaccine may be providing protection during this pandemic of SARS-CoV-2.
COVID-19, RUBELLA, MEASLES VIRUS
Vaccines for measles, mumps and rubella came out in the early 1960’s. So those over 60 may not have received the vaccine. Coronavirus appears to be deadlier in this same population.
The MMR is given to children between 12-15 months with a booster at 4-6 years old.
Study authors write:
Taken together, our preliminary data would support the hypothesis that rubella vaccination could provide protection against poor outcome in COVID-19 infection. To determine if there is a potential effect of MMR vaccinations, it would be necessary to know the vaccination status of younger patients infected with SARS-CoV-2 and the severity of the disease. If there is a link, we propose that vaccination of ‘at risk’ age groups with an MMR vaccination should be considered as a time-appropriate and safe intervention. To create a SARS-CoV-2 vaccine will be arduous and may require time which we simply cannot afford. Meanwhile, some help could be immediately available to those in the greatest need.
Again the MMR vaccine may not prevent COVID infection but could be a reason for less severity in some patients.
Original article written by Dr. Daliah.
